Publication: Efficacy and safety of maralixibat in patients with progressive familial intrahepatic cholestasis (march-pfic): a randomized placebo-controlled phase 3 study
| dc.contributor.coauthor | Miethke, Alexander | |
| dc.contributor.coauthor | Moukarzel, Adib | |
| dc.contributor.coauthor | Porta, Gilda | |
| dc.contributor.coauthor | Esquer, Joshue Covarrubias | |
| dc.contributor.coauthor | Czubkowski, Piotr | |
| dc.contributor.coauthor | Ordonez, Felipe | |
| dc.contributor.coauthor | Candusso, Manila | |
| dc.contributor.coauthor | Aqul, Amal A. | |
| dc.contributor.coauthor | Squires, Robert H. | |
| dc.contributor.coauthor | Sokal, Etienne | |
| dc.contributor.coauthor | D'Agostino, Daniel | |
| dc.contributor.coauthor | Baumann, Ulrich | |
| dc.contributor.coauthor | D'Antiga, Lorenzo | |
| dc.contributor.coauthor | Kasi, Nagraj | |
| dc.contributor.coauthor | Laborde, Nolwenn | |
| dc.contributor.coauthor | Lin, Chuan-Hao | |
| dc.contributor.coauthor | Gilmour, Susan | |
| dc.contributor.coauthor | Mittal, Naveen | |
| dc.contributor.coauthor | Chiou, Fang Kuan | |
| dc.contributor.coauthor | Horslen, Simon P. | |
| dc.contributor.coauthor | Huber, Wolf-Dietrich | |
| dc.contributor.coauthor | Van Leerberghe, Arthur | |
| dc.contributor.coauthor | Ronn, Susanne Weber | |
| dc.contributor.coauthor | Nunes, Tiago | |
| dc.contributor.coauthor | Lascau, Anamaria | |
| dc.contributor.coauthor | Longpre, Lara | |
| dc.contributor.coauthor | Garner, Will | |
| dc.contributor.coauthor | Vig, Pamela | |
| dc.contributor.coauthor | Hupertz, Vera F. | |
| dc.contributor.coauthor | Gonzalez-Peralta, Regino P. | |
| dc.contributor.coauthor | Ekong, Udeme | |
| dc.contributor.coauthor | Hartley, Jane | |
| dc.contributor.coauthor | Laverdure, Noemie | |
| dc.contributor.coauthor | Ovchinsky, Nadia | |
| dc.contributor.coauthor | Thompson, Richard J. | |
| dc.contributor.department | School of Medicine | |
| dc.contributor.kuauthor | Faculty Member, Arıkan, Çiğdem | |
| dc.contributor.schoolcollegeinstitute | SCHOOL OF MEDICINE | |
| dc.date.accessioned | 2024-12-29T09:37:38Z | |
| dc.date.issued | 2023 | |
| dc.description.indexedby | WOS | |
| dc.description.issue | 5 | |
| dc.description.publisherscope | International | |
| dc.description.sponsoredbyTubitakEu | N/A | |
| dc.description.volume | 77 | |
| dc.identifier.eissn | 1527-3350 | |
| dc.identifier.issn | 0270-9139 | |
| dc.identifier.quartile | Q1 | |
| dc.identifier.uri | https://hdl.handle.net/20.500.14288/22432 | |
| dc.identifier.wos | 1034828200003 | |
| dc.keywords | Gastroenterology | |
| dc.keywords | Hepatology | |
| dc.language.iso | eng | |
| dc.publisher | Lippincott Williams & Wilkins | |
| dc.relation.ispartof | Hepatology | |
| dc.subject | Gastroenterology and hepatology | |
| dc.title | Efficacy and safety of maralixibat in patients with progressive familial intrahepatic cholestasis (march-pfic): a randomized placebo-controlled phase 3 study | |
| dc.type | Meeting Abstract | |
| dspace.entity.type | Publication | |
| local.contributor.kuauthor | Arıkan, Çiğdem | |
| local.publication.orgunit1 | SCHOOL OF MEDICINE | |
| local.publication.orgunit2 | School of Medicine | |
| relation.isOrgUnitOfPublication | d02929e1-2a70-44f0-ae17-7819f587bedd | |
| relation.isOrgUnitOfPublication.latestForDiscovery | d02929e1-2a70-44f0-ae17-7819f587bedd | |
| relation.isParentOrgUnitOfPublication | 17f2dc8e-6e54-4fa8-b5e0-d6415123a93e | |
| relation.isParentOrgUnitOfPublication.latestForDiscovery | 17f2dc8e-6e54-4fa8-b5e0-d6415123a93e |
